Amrutanjan Health Care Ltd (AMRUTANJAN) — Board Meeting | 23 September 2026

23 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Shareholders approved audited financials, declared ₹2.90 dividend, and reappointed Ms. Ramaa Prabhakar as director.

🔄 What Changed

Final dividend declared at ₹2.90 per share; reappointment of Ms. Ramaa Prabhakar as non-executive director.

💡 Investor Takeaway

The dividend signals shareholder-friendly policy, but reappointment of a director may raise governance concerns without further context.

Amrutanjan Health Care held its 89th AGM on September 23, 2026, where shareholders approved the audited financial statements, declared a final dividend of ₹2.90 per share, and reappointed Ms. Ramaa Prabhakar as a non-executive director. The meeting featured a presentation on financial performance, key business highlights, and strategic growth pillars, with 120 shareholders participating via video conference.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMRUTANJAN ✨ Ask AI About This

About Amrutanjan Health Care Ltd (AMRUTANJAN)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹1,463.31 CrP/E: 27.1ROE: 49.6%ROCE: 65.5%Div Yield: 0.76%

View full AMRUTANJAN stock details →

📡 Get AI alerts when AMRUTANJAN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMRUTANJAN — Free

💡 Ask AI about this filing

"How does ₹2.90 dividend compare to peers' payout ratios?""What are the strategic growth pillars outlined for future revenue?""How will e-voting adoption affect shareholder participation rates?"

Ask AI Free →

📊 More AMRUTANJAN filings

Announcement — 25 September 2026Amrutanjan Health Care Ltd announced that its designated insiders must remain in a closed trading wi...
🟡 Voting Results — 24 September 2026Amrutanjan Health Care held its 89th AGM on September 23, 2026 via video conference, with 28,910,630...
🔴 Annual Report — 28 August 2026Amrutanjan Health Care Ltd reported FY26 revenue of ₹50,255.27 crore, up 10% YoY, with PAT at ₹5,791...
🟡 Sustainability Report — 28 August 2026Amrutanjan Health Care Ltd's BRSR filing highlights robust growth in OTC and women's hygiene segment...
Announcement — 12 August 2026Amrutanjan Health Care reported Q1 FY27 net sales of ₹102.97 crores, up 9.48% YoY, driven by strong ...

See all AMRUTANJAN filings →

🔥 Also filed on 23 September 2026

PFOCUSPrime Focus LtdAnnouncement 501261Lords Mark Industries LimitedAnnouncement GREENPOWEROrient Green Power Company LtdCorporate Action PFOCUSPrime Focus LtdAnnouncement GSFCGujarat State Fertilizers & Chemicals LtdAnnouncement GLENMARKGlenmark Pharmaceuticals LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMRUTANJAN files new disclosures

Track AMRUTANJAN filings, board meetings, and corporate actions. Free email alerts at 5 PM.